Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Colorectal Neoplasms × Sunitinib × Clear all

Phase

Status

Completed 6 Terminated 3 Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Renal Cell 12 Neoplasm Metastasis 5 Kidney Neoplasms 5 Breast Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Glioblastoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Uveal Melanoma 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Ovarian Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hormone Refractory Prostate Cancer 1 Gastrointestinal Stromal Tumors 1 Gastrointestinal Neoplasms 1 Fatigue 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Carcinoma 1 Carcinoid Tumor 1 Brain Neoplasms 1

Interventions

Fluorouracil 68 Oxaliplatin 62 Leucovorin 53 Irinotecan 53 Capecitabine 51 Bevacizumab 51 Cetuximab 41 Folfox protocol 20 Drug Therapy 20 Neoadjuvant Therapy 18 HMPL-013 15 regorafenib 13 Colonoscopy 13 apatinib 11 XELOX 10 Chemotherapy, Adjuvant 10 raltitrexed 9 Radiotherapy 9 trifluridine tipiracil drug combination 8 sintilimab 8 Surveys and Questionnaires 8 Surgical Procedures, Operative 8 Panitumumab 8 IFL protocol 8 Blood Specimen Collection 8 tislelizumab 7 Laparoscopy 7 Endoscopic Mucosal Resection 7 Aspirin 7 Trastuzumab 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03909724 2020-11-13

SUNRISE-CRC

Amsterdam UMC, location VUmc

Phase 2/3 Unknown

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡